SSS
Scribe Therapeutics Inc.
No trades
No trades
Compare with Scribe Therapeutics Inc.
−21.81 M USD
51.17 M USD
12.09 M
Last report date
Sep 2, 2026
Report period
Q2 2026
EPS
−2.62 USD
Revenue
1.90 M USD
Company info
Sector
Industry
CEO
Benjamin L. Oakes
Website
Headquarters
Alameda
Founded
2017
IPO date
Jul 24, 2026
IPO offer price
15.00 USD
ISIN
US8110331092
CUSIP
811033109
FIGI
BBG00RR3PF94
Identifiers
ISIN US8110331092
Scribe Therapeutics, Inc. is a clinical-stage biotechnology company. It is engaged in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded in June 2017 by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Alameda, CA.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently asked questions
The current price of SCTX is 31.92 USD — it has increased by 7.61% in the past 24 hours. Watch Scribe Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Scribe Therapeutics Inc. stocks are traded under the ticker SCTX.
SCTX stock has risen by 13.07% compared to the previous week, the month change is a 54.21% rise, over the last year Scribe Therapeutics Inc. has showed a 48.60% increase.
We've gathered analysts' opinions on Scribe Therapeutics Inc. future price: according to them, SCTX price has a max estimate of 60.00 USD and a min estimate of 50.00 USD. Watch SCTX chart and read a more detailed Scribe Therapeutics Inc. stock forecast: see what analysts think of Scribe Therapeutics Inc. and suggest that you do with its stocks.
SCTX reached its all-time high on Aug 20, 2026 with the price of 39.60 USD, and its all-time low was 17.31 USD and was reached on Jul 27, 2026. View more price dynamics on SCTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SCTX stock is 9.68% volatile and has beta coefficient of −1.83. Track Scribe Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Scribe Therapeutics Inc. there?
Today Scribe Therapeutics Inc. has the market capitalization of 599.38 M, it has decreased by −8.52% over the last week.
Yes, you can track Scribe Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Scribe Therapeutics Inc. is going to release the next earnings report on Dec 2, 2026. Keep track of upcoming events with our Earnings Calendar.
SCTX earnings for the last quarter are −2.62 USD per share, whereas the estimation was −3.62 USD resulting in a 27.58% surprise. The estimated earnings for the next quarter are −0.85 USD per share. See more details about Scribe Therapeutics Inc. earnings.
Scribe Therapeutics Inc. revenue for the last quarter amounts to 1.90 M USD, despite the estimated figure of 3.11 M USD. In the next quarter, revenue is expected to reach 3.72 M USD.
SCTX net income for the last quarter is −6.48 M USD, while the quarter before that showed −17.35 M USD of net income which accounts for 0.00% change. Track more Scribe Therapeutics Inc. financial stats to get the full picture.
No, SCTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 16, 2026, the company has 98 employees. See our rating of the largest employees — is Scribe Therapeutics Inc. on this list?
Like other stocks, SCTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Scribe Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.